title: Diabetes and Amoebiasis: a high risk encounter.
abstract: Amoebiasis is the second most common parasitic disease worldwIde. It occurs mainly in developing countries. A high percentage of people in countries where it is endemic are asymptomatic carriers. It results in severe disease that can be fatal in rare cases. Diabetics are at increased risk of exposure as travel to countries where it is endemic becomes more frequent, as indicated by the present case. This patient suffered from amoebiasis that produced an amoeboma which is most rare in cases of colonic amoebiasis. The clinical picture was that of an occluding gut tumor, but it was treated only with drugs. Retrospective studies show that diabetics are at increased risk of suffering severe complications after amoebic infection. The frequency and severity of this diabetes-amoeba association requires patients to take prophylactic measures, especially when travelling in developing countries.
authors.affiliation: Service de pathologie digestive, Hôpital d'Instruction des Armées Bégin, 94160 Saint Mandé, France.
authors.forename: C
authors.initials: C
authors.lastname: Bredin
authors.forename: J
authors.initials: J
authors.lastname: Margery
authors.forename: L
authors.initials: L
authors.lastname: Bordier
authors.forename: H
authors.initials: H
authors.lastname: Mayaudon
authors.forename: O
authors.initials: O
authors.lastname: Dupuy
authors.forename: B
authors.initials: B
authors.lastname: Vergeau
authors.forename: B
authors.initials: B
authors.lastname: Bauduceau
mesh_terms: D000368:Aged; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D003106:Colon / Q000469:parasitology; D048909:Diabetes Complications; D004338:Drug Combinations; D004748:Entamoeba histolytica / Q000302:isolation & purification; D004749:Entamoebiasis / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D015125:Oxyquinoline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011859:Radiography; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D004338:Drug Combinations; D008795:Metronidazole; D015125:Oxyquinoline; C037666:intetrix